Joel Isaacson & Co., LLC Abb Vie Inc. Transaction History

Joel Isaacson & Co., LLC

$2.07 Billion
Q3 2024

A detailed history of Joel Isaacson & Co., LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Joel Isaacson & Co., LLC holds 6,181 shares of ABBV stock, worth $1.11 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

6,181

Previous 6,278 1.55%

Holding current value

$1.11 Million

Previous $1.08 Million 13.38%

% of portfolio

0.06%

Previous 0.06%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$163.84 - $199.33 $15,892 - $19,335	-97 Reduced 1.55%	6,181 $1.22 Million
Q2 2024 Jul 23, 2024	SELL	$154.79 - $180.76 $52,164 - $60,916	-337 Reduced 5.09%	6,278 $1.08 Million
Q1 2024 Apr 29, 2024	SELL	$159.82 - $182.1 $11,986 - $13,657	-75 Reduced 1.12%	6,615 $1.2 Million
Q4 2023 Jan 24, 2024	BUY	$137.6 - $154.97 $30,272 - $34,093	220 Added 3.4%	6,690 $1.04 Million
Q3 2023 Oct 23, 2023	BUY	$133.59 - $154.65 $400 - $463	3 Added 0.05%	6,470 $964,000
Q2 2023 Jul 26, 2023	SELL	$132.51 - $164.9 $12,853 - $15,995	-97 Reduced 1.48%	6,467 $871,000
Q1 2023 Apr 24, 2023	SELL	$144.61 - $166.54 $6,507 - $7,494	-45 Reduced 0.68%	6,564 $1.05 Million
Q4 2022 Jan 27, 2023	SELL	$138.31 - $165.87 $73,304 - $87,911	-530 Reduced 7.42%	6,609 $0
Q3 2022 Oct 13, 2022	BUY	$134.21 - $153.93 $54,757 - $62,803	408 Added 6.06%	7,139 $958,000
Q2 2022 Jul 15, 2022	BUY	$137.62 - $174.96 $53,671 - $68,234	390 Added 6.15%	6,731 $1.03 Million
Q1 2022 Apr 21, 2022	BUY	$131.98 - $163.75 $21,776 - $27,018	165 Added 2.67%	6,341 $1.01 Million
Q4 2021 Jan 19, 2022	SELL	$107.43 - $135.93 $214 - $271	-2 Reduced 0.03%	6,176 $836,000
Q3 2021 Oct 21, 2021	BUY	$106.4 - $120.78 $7,341 - $8,333	69 Added 1.13%	6,178 $666,000
Q2 2021 Jul 20, 2021	SELL	$105.21 - $117.21 $53,867 - $60,011	-512 Reduced 7.73%	6,109 $688,000
Q4 2020 Jan 22, 2021	BUY	$80.49 - $108.67 $5,312 - $7,172	66 Added 1.01%	6,621 $709,000
Q3 2020 Oct 14, 2020	BUY	$85.91 - $100.83 $9,278 - $10,889	108 Added 1.68%	6,555 $574,000
Q2 2020 Jul 21, 2020	BUY	$73.37 - $98.18 $31,108 - $41,628	424 Added 7.04%	6,447 $633,000
Q1 2020 Apr 21, 2020	BUY	$64.5 - $97.79 $41,280 - $62,585	640 Added 11.89%	6,023 $459,000
Q4 2019 Jan 24, 2020	BUY	$72.13 - $90.25 $36,065 - $45,125	500 Added 10.24%	5,383 $477,000
Q3 2019 Oct 15, 2019	BUY	$62.98 - $75.72 $22,735 - $27,334	361 Added 7.98%	4,883 $370,000
Q2 2019 Jul 11, 2019	SELL	$65.7 - $83.98 $53,676 - $68,611	-817 Reduced 15.3%	4,522 $329,000
Q1 2019 Apr 09, 2019	BUY	$77.14 - $90.79 $19,285 - $22,697	250 Added 4.91%	5,339 $430,000
Q4 2018 Jan 18, 2019	BUY	$77.85 - $96.01 $51,614 - $63,654	663 Added 14.98%	5,089 $449,000
Q2 2018 Aug 01, 2018	BUY	$89.78 - $106.23 $44,890 - $53,115	500 Added 12.74%	4,426 $410,000
Q4 2017 Jan 30, 2018	SELL	$89.56 - $98.21 $8,956 - $9,821	-100 Reduced 2.48%	3,926 $380,000
Q3 2017 Nov 02, 2017	BUY	$69.85 - $89.22 $281,216 - $359,199	4,026	4,026 $358,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Joel Isaacson & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Joel Isaacson & Co., LLC with notifications on news.

Account

Joel Isaacson & Co., LLC Abb Vie Inc. Transaction History